Mingfeng Zhao

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Venues

Annals of hematology

Current treatment options in oncology

Leukemia

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey V Stepanov, Alexander G Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia 38 (6) (2024)
Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey V Stepanov, Alexander G Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia 38 (6) (2024)
Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey V Stepanov, Alexander G Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia 38 (6) (2024)
Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey V Stepanov, Alexander G Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia (2024)
Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey V Stepanov, Alexander G Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia 38 (6) (2024)
Wenyi Lu, Hairong Lyu, Xia Xiao, Xue Bai, Meng Zhang, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey V Stepanov, Alexander G Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia 38 (6) (2024)
Yuxin An, Xin Jin, Hongkai Zhang, Meng Zhang, Sadhana Mahara, Wenyi Lu, Mingfeng Zhao
"Off-the-Shelf" Allogeneic CAR Cell Therapy-Neglected HvG Effect. Current treatment options in oncology (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology 102 (6) (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology (2023)
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu, Mingfeng Zhao
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current treatment options in oncology 24 (3) (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology 102 (6) (2023)
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu, Mingfeng Zhao
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current treatment options in oncology 24 (3) (2023)
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu, Mingfeng Zhao
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current treatment options in oncology 24 (3) (2023)
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu, Mingfeng Zhao
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current treatment options in oncology 24 (3) (2023)
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu, Mingfeng Zhao
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current treatment options in oncology 24 (3) (2023)
Xuejin Gao, Jile Liu, Rui Sun, Jingkun Zhang, Xinping Cao, Yi Zhang, Mingfeng Zhao
Alliance between titans: combination strategies of CAR-T cell therapy and oncolytic virus for the treatment of hematological malignancies. Annals of hematology (2023)
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu, Mingfeng Zhao
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current treatment options in oncology (2023)
Xia Xiong, Yibing Yu, Xin Jin, Danni Xie, Rui Sun, Wenyi Lu, Yunxiong Wei, Ruiting Guo, Mingfeng Zhao
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells. Annals of hematology 102 (6) (2023)
Yunxiong Wei, Xia Xiong, Xin Li, Wenyi Lu, Xiaoyuan He, Xin Jin, Rui Sun, Hairong Lyu, Ting Yuan, Tongtong Sun, Mingfeng Zhao
Low-dose decitabine plus venetoclax is safe and effective as post-transplant maintenance therapy for high-risk acute myeloid leukemia and myelodysplastic syndrome. Cancer science 112 (9) (2021)
Wenyi Lu, Yunxiong Wei, Yaqing Cao, Xia Xiao, Qing Li, Hairong Lyu, Yili Jiang, Huan Zhang, Xin Li, Yanyu Jiang, Juanxia Meng, Ting Yuan, Haibo Zhu, Xiaoyuan He, Xin Jin, Rui Sun, Tao Sui, Kaiqi Liu, Mingfeng Zhao
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease. Cancer immunology, immunotherapy : CII 70 (12) (2021)

Mingfeng Zhao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mingfeng Zhao